Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Cytochrome P450 (CYP) 1B1 Enzyme with Four Series of A-Ring Substituted Estrane Derivatives: Design, Synthesis, Inhibitory Activity, and Selectivity
Raphaël Dutour, Jenny Roy, Francisco Cortés‐Benítez, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 20, pp. 9229-9245
Closed Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Acetylene Group, Friend or Foe in Medicinal Chemistry
Tanaji T. Talele
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 11, pp. 5625-5663
Closed Access | Times Cited: 105
Drug-Metabolizing Cytochrome P450 Enzymes Have Multifarious Influences on Treatment Outcomes
Yurong Song, Chenxi Li, Guangzhi Liu, et al.
Clinical Pharmacokinetics (2021) Vol. 60, Iss. 5, pp. 585-601
Closed Access | Times Cited: 66
New Advances in the Research of Resistance to Neoadjuvant Chemotherapy in Breast Cancer
Junsha An, Cheng Peng, Hailin Tang, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9644-9644
Open Access | Times Cited: 62
Carvedilol serves as a novel CYP1B1 inhibitor, a systematic drug repurposing approach through structure-based virtual screening and experimental verification
Ying Wang, Xiaomei He, Chunshi Li, et al.
European Journal of Medicinal Chemistry (2020) Vol. 193, pp. 112235-112235
Closed Access | Times Cited: 40
Accelerating Drug Discovery by Early Protein Drug Target Prediction Based on a Multi-Fingerprint Similarity Search †
Michele Montaruli, Domenico Alberga, Fulvio Ciriaco, et al.
Molecules (2019) Vol. 24, Iss. 12, pp. 2233-2233
Open Access | Times Cited: 40
Design and synthesis of α-naphthoflavone chimera derivatives able to eliminate cytochrome P450 (CYP)1B1-mediated drug resistance via targeted CYP1B1 degradation
Li Zhou, Wen-Ming Chen, Chenyang Cao, et al.
European Journal of Medicinal Chemistry (2020) Vol. 189, pp. 112028-112028
Closed Access | Times Cited: 37
Overcoming Taxol-resistance in A549 cells: A comprehensive strategy of targeting P-gp transporter, AKT/ERK pathways, and cytochrome P450 enzyme CYP1B1 by 4-hydroxyemodin
Hao Lin, Baichun Hu, Xiaomei He, et al.
Biochemical Pharmacology (2019) Vol. 171, pp. 113733-113733
Closed Access | Times Cited: 34
Metal-Free Aerobic Oxidative Selective C–C Bond Cleavage in Heteroaryl-Containing Primary and Secondary Alcohols
Anjie Xia, Xueyu Qi, Xin Mao, et al.
Organic Letters (2019) Vol. 21, Iss. 9, pp. 3028-3033
Closed Access | Times Cited: 28
Development of Novel N-Aryl-2,4-bithiazole-2-amine-Based CYP1B1 Degraders for Reversing Drug Resistance
Xiaoxuan Yao, Jianping Mao, Haoyu Zhang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 272, pp. 116488-116488
Closed Access | Times Cited: 2
Current insights into environmental acetochlor toxicity and remediation strategies
Wenjuan Chen, Shao-Fang Chen, Haoran Song, et al.
Environmental Geochemistry and Health (2024) Vol. 46, Iss. 9
Closed Access | Times Cited: 2
Multiple machine learning, molecular docking, and ADMET screening approach for identification of selective inhibitors of CYP1B1
Baddipadige Raju, Himanshu Verma, Gera Narendra, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 17, pp. 7975-7990
Closed Access | Times Cited: 19
New Perspectives of CYP1B1 Inhibitors in the Light of Molecular Studies
Renata Mikstacka, Zbigniew Dutkiewicz
Processes (2021) Vol. 9, Iss. 5, pp. 817-817
Open Access | Times Cited: 19
Design and synthesis of selective CYP1B1 inhibitor via dearomatization of α-naphthoflavone
Makoto Kubo, Keiko Yamamoto, Toshimasa Itoh
Bioorganic & Medicinal Chemistry (2018) Vol. 27, Iss. 2, pp. 285-304
Closed Access | Times Cited: 21
Design, Synthesis, and Biological Evaluation of Cytochrome P450 1B1 Targeted Molecular Imaging Probes for Colorectal Tumor Detection
Qingqing Meng, Zengtao Wang, Jiahua Cui, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 23, pp. 10901-10909
Closed Access | Times Cited: 19
Cobalt(III)-Catalyzed Oxidative Annulation of Benzaldehydes with Internal Alkynes via C–H Functionalization in Poly(ethylene glycol)
Li‐Ming Tao, Chuan‐Hua Li, Jun Chen, et al.
The Journal of Organic Chemistry (2019) Vol. 84, Iss. 11, pp. 6807-6812
Closed Access | Times Cited: 18
α-naphthoflavone-derived cytochrome P450 (CYP)1B1 degraders specific for sensitizing CYP1B1-mediated drug resistance to prostate cancer DU145: Structure activity relationship
Peng Chen, Shaobing Wang, Chenyang Cao, et al.
Bioorganic Chemistry (2021) Vol. 116, pp. 105295-105295
Closed Access | Times Cited: 14
Structure-Based Drug Design and Synthesis of Novel N-Aryl-2,4-bithiazole-2-amine CYP1B1-Selective Inhibitors in Overcoming Taxol Resistance in A549 Cells
Jianping Mao, Dong Wang, Ping Xu, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 24, pp. 16451-16480
Closed Access | Times Cited: 10
CYP1B1: A Promising Target in Cancer Drug Discovery
Marciéli Fábris, Mariana Luiza Silva, Kaio Maciel de Santiago-Silva, et al.
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 23, Iss. 9, pp. 981-988
Closed Access | Times Cited: 5
Multistep Synthesis and In Vitro Anticancer Evaluation of 2-Pyrazolyl-Estradiol Derivatives, Pyrazolocoumarin-Estradiol Hybrids and Analogous Compounds
Barnabás Molnár, Mohana Krishna Gopisetty, Dóra Izabella Adamecz, et al.
Molecules (2020) Vol. 25, Iss. 18, pp. 4039-4039
Open Access | Times Cited: 15
Design of Cytochrome P450 1B1 Inhibitors via a Scaffold-Hopping Approach
Austin C. Hachey, Alexander D. Fenton, David K. Heidary, et al.
Journal of Medicinal Chemistry (2022) Vol. 66, Iss. 1, pp. 398-412
Closed Access | Times Cited: 9
Pd-catalyzed Suzuki–Miyaura couplings and evaluation of 13α-estrone derivatives as potential anticancer agents
Rebeka Jójárt, H. Abu Ali, Gergely Horváth, et al.
Steroids (2020) Vol. 164, pp. 108731-108731
Open Access | Times Cited: 10
Synthesis and conversion of primary and secondary 2-aminoestradiols into A-ring-integrated benzoxazolone hybrids and their in vitro anticancer activity
Ferenc Kovács, Mohana Krishna Gopisetty, Dóra Izabella Adamecz, et al.
RSC Advances (2021) Vol. 11, Iss. 23, pp. 13885-13896
Open Access | Times Cited: 10
Design, Synthesis, and Evaluation of 18F-Labeling CYP1B1 PET Tracer Based on 2-Phenylquinazolin
Jiajing Cai, Lan Yi, Xia Zhu, et al.
Bioorganic & Medicinal Chemistry Letters (2023) Vol. 96, pp. 129533-129533
Closed Access | Times Cited: 2
Transition metal-catalysed A-ring C–H activations and C(sp2)–C(sp2) couplings in the 13α-oestrone series and in vitro evaluation of antiproliferative properties
Péter Traj, Ali Hazhmat Abdolkhaliq, Anett Németh, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 895-902
Open Access | Times Cited: 6
Design, Synthesis and Binding Affinity Evaluation of Cytochrome P450 1B1 Targeted Chelators
Dongmei Chen, Qiqi Fan, Ting Xu, et al.
Anti-Cancer Agents in Medicinal Chemistry (2021) Vol. 22, Iss. 2, pp. 261-269
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top